Evidence map›Paper›PMID 40699106›Full record

Observational studyArquivos brasileiros de oftalmologia2025

Artificial intelligence-based model for the interpretation and reporting of standard automated perimetry.

Joacy Pedro Franco David, Alexandre Antonio Marques Rosa, Rafael Scherer, Cláudio Eduardo Corrêa Teixeira, Douglas Costa

Abstract readObservational Study
In one paragraph

Observational study in Arquivos brasileiros de oftalmologia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Joacy Pedro Franco DavidUniversidade Federal do Pará, Belém, PA, Brazil.ORCID 0000-0001-9224-451X
Alexandre Antonio Marques RosaUniversidade Federal do Pará, Belém, PA, Brazil.ORCID 0000-0001-5496-9704
Rafael SchererBascom Palmer Eye Institute, Miami, Miami, FL, United States of America.ORCID 0000-0002-0322-7900
Cláudio Eduardo Corrêa TeixeiraCentro Universitário Estado do Pará, Belém, PA, Brazil.ORCID 0000-0003-4889-9265
Douglas CostaBascom Palmer Eye Institute, Miami, Miami, FL, United States of America.ORCID 0000-0002-9156-3196

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeStandard automated perimetry has been the standard method for measuring visual field changes for several years. It can measure an individual's ability to detect a light stimulus from a uniformly illuminated background. In the management of glaucoma, the primary objective of perimetry is the identification and quantification of visual field abnormalities. It also serves as a longitudinal evaluation for the detection of disease progression. The development of artificial intelligence--based models capable of interpreting tests could combine technological development with improved access to healthcare.

methodsIn this observational, cross-sectional, descriptive study, we used an artificial intelligence-based model [Inception V3] to interpret gray-scale crops from standard automated perimetry that were performed in an ophthalmology clinic in the Brazilian Amazon rainforest between January 2018 and December 2022.

resultsThe study included 1,519 standard automated perimetry test results that were performed using Humphrey HFA-II-i-750 (Zeiss Meditech). The Subsequently, 70%, 10%, and 20% of the dataset were used for training, validation, and testing, respectively. The model achieved 80% (68.23%-88.9%) sensitivity and 94.64% (88.8%-98%) specificity for detecting altered perimetry results. Furthermore, the area under the receiver operating characteristic curve was 0.93.

conclusionsThe integration of artificial intelligence in the diagnosis, screening, and monitoring of pathologies represents a paradigm shift in ophthalmology, enabling significant improvements in safety, efficiency, availability, and accessibility of treatment.

Indexed as

Artificial IntelligenceGlaucomaVisual FieldsVisual Field TestsAdultBrazilCross-Sectional StudiesFemaleHumansMaleMiddle AgedReproducibility of ResultsSensitivity and Specificity

Identifiers

PMID40699106
PMCPMC12997573

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.